Rongjing Ding

Rongjing Ding

Auto-generated profile, based on publicly available information

Rongjing Ding

Department of Rehabilitation Medicine, Dongcheng District, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Beijing, 100730, China.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 August 2015 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
PDF file
JZJie Zhuang
Jie Zhuang
yiqiang zhanyiqiang zhan
yiqiang zhan
FZFen Zhang
Fen Zhang
ZTZheng Tang
Zheng Tang
JWJinsong Wang
Jinsong Wang
JYJinming Yu
Jinming Yu
Objective: We aimed to investigate the association between self-reported insomnia and coronary heart diseases in the elderly Chinese population. Methods and results: A cross-sectional study was conducted in the Beijing and 2982 participants aged ≥60 years were recruited. The association between self-reported insomnia and coronary heart diseases (CHD) was determined by multiple logistic regression models. Age, gender, education, obesity, physical activity, current smoking, current drinking, medication, hypertension, diabetes, tea consumption, heart rate, and dyslipidemia were adjusted as confounders. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were reported as effect measurements. The numbers of subjects with no insomnia, occasional insomnia, and frequent insomnia were 2110 (70.76%), 509(17.07%), and 363 (12.17%), respectively. The prevalence of CHD in those with no insomnia, occasional insomnia, and frequent insomnia were 13.65%, 16.31%, and 22.31%. Compared with subjects with no insomnia, the multivariate adjusted ORs and 95% CIs for those with occasional insomnia and frequent insomnia were 1.17 (0.89–1.54) and 1.73 (1.30–2.31), respectively. There was no significant difference of the association between men and women. Conclusions: Self-reported insomnia is associated with high risks of CHD in the elderly Chinese population.

5 May 2019 in Chinese Medical Journal
Verified
Journal Article
Open access
KXKun Xia
Kun Xia
LWLe-Feng Wang
Le-Feng Wang
XYXin-Chun Yang
Xin-Chun Yang
HJHong-Yan Jiang
Hong-Yan Jiang
LZLi-Jing Zhang
Li-Jing Zhang
RDRong-Jing Ding
Rong-Jing Ding
Depression and anxiety have been correlated with elevated risks for quality-of-life (QOL), adverse outcomes and medical expenditure in patients with acute coronary syndrome (ACS). However, the relevant data are lacking for Chinese ACS populations, especially regarding different effects of major depression, anxiety and comorbidity. The objective of this study was to evaluate the dynamic changes of depression and/or anxiety over 12 months and examine the effects of depression, anxiety and comorbidity on QOL, adverse outcomes and medical expenditure in Chinese ACS patients. For this prospective longitudinal study, a total of 647 ACS patients were recruited from North China between January 2013 and June 2015. Among them, 531 patients (82.1%) completed 12-month follow-ups. Logistic regression model was utilized for analyzing the association of baseline major depression, anxiety and comorbidity with 12-month all-cause mortality, cardiovascular events, QOL and health expenditure. During a follow-up period of 12 months, 7.3% experienced non-fatal myocardial infarction (MI) and 35.8% cardiac rehospitalization. Baseline comorbidity, rather than major depression/anxiety, strongly predicted poor 12-month QOL as measured by SF-12 (OR: 1.77, 95%CI: 1.22–2.52, p = 0.003). Regarding 12-month non-fatal MI and cardiac rehospitalization, baseline anxiety (OR: 2.83, 95%CI: 1.33–5.89, p < 0.01; OR: 4.47, 95%CI: 1.50–13.00, p < 0.01), major depression (OR: 2.58, 95% CI: 1.02–6.15, p < 0.05; OR: 5.22, 95%CI: 1.42–17.57, p < 0.03) and comorbidity (OR: 6.33, 95%CI: 2.96–13.79, p < 0.0001, OR: 14.08, 95%CI: 4.99–41.66, p < 0.0001) were all independent predictors. And comorbidity had the highest predictive value. Number of rehospitalization stay, admission frequency within 12 months and medical expenditure within 2 months were the highest in ACS patients with comorbidity. Major depression and anxiety may predict 12-month non-fatal MI and cardiac rehospitalization. However comorbidity has the highest predictive value with greater medical expenditure and worse QOL in Chinese ACS patients. And depression with comorbid anxiety may be a new target of mood status in ACS patients. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0


19 April 2023 in Heliyon
Verified
Journal Article
Open access
QWQingwei Wang
Qingwei Wang
FJFei Jiang
Fei Jiang
CZChenglin Zhao
Chenglin Zhao
JSJiaxin Song
Jiaxin Song
MHMeiyu Hu
Meiyu Hu
YQYan Qiu
Yan Qiu
Cardiomyocyte apoptosis has been characterized as one of the major mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy. MicroRNA-21-5p (miR-21-5p) was reported to mitigate ischemia-induced cardiomyocyte apoptosis and cardiac injury. However, to our knowledge, the functional role of miR-21-5p in DOX-induced cardiomyopathy is unclear. In this study, we explored the role of miR-21-5p in DOX-induced cardiac injury. The expression level of miR-21-5p was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Dual luciferase reporter assay was used to verify the potential target gene of miR-21-5p. The apoptosis rate of NRCMs was detected by TUNEL staining assay. Western blot analysis was used to detect the protein expression levels of Bax, Bcl-2, Caspase3, cleaved-Caspase3 and BTG2. For animal studies, mice were injected with AAV9-miR-21-5p or AAV9-Empty viruses, and treated with DOX at a dose of 5 mg/kg per week through intraperitoneally administration. After 4 weeks of DOX treatment, mice were subjected to echocardiography to measure the left ventricular ejection fraction (EF) and fractional shortening (FS). Results showed that miR-21-5p was upregulated in both DOX-treated primary cardiomyocytes and mouse heart tissues. Interestingly, enhanced miR-21-5p expression inhibited DOX-induced cardiomyocyte apoptosis and oxidative stress, while decreased miR-21-5p expression promoted cardiomyocyte apoptosis and oxidative stress. Furthermore, cardiac overexpression of miR-21-5p protected against DOX-induced cardiac injury. The mechanistic study indicated that BTG2 was a target gene of miR-21-5p. The anti-apoptotic effect of miR-21-5p could be inhibited by BTG2 overexpression. Conversely, inhibition of BTG2 rescued the pro-apoptotic effect of miR-21-5p inhibitor. Taken together, our study showed that miR-21-5p could prevent DOX-induced cardiomyopathy by downregulating BTG2.

6 May 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
QSQu Shan
Qu Shan
XSXinxin Shi
Xinxin Shi
XZXie Zhijuan
Xie Zhijuan
DRDing Rongjing
Ding Rongjing
ZMZheng Minjie
Zheng Minjie
Background: AF Patients with depression resulted in a markedly reduced quality of life. The purpose of this study was to evaluate the efficacy of cognitive behavior therapy (CBT) on the health-related quality of life (HRQoL).Methods: It was A longitudinal randomized controlled trial with a pre and 12-weeks post-test. Ninety persons were randomly assigned to either a CBT group (CBT) (n = 45) or a treatment as usual (TAU) group (n = 45). The outcome were changes in the HRQoL [12-item Short Form Health Survey, SF12, divided into two domains: the physical component summary (PCS) and the mental component summary (MCS)], changes in psychological distress [Hamilton Depression Rating Scale (HAM-D) and Patient Health Questionnaire-9 (PHQ-9)], and Illness Perception [Brief Illness Perception Questionnaire (BIPQ)].Results: There were statistically significant differences in score reduction for PHQ-9 (t = 3.186, P = 0.002), HAMD (t = 2.611, P = 0.011), BIPQ (t = 7.660, P < 0.001), and MCS (t = 4.301, P < 0.001) between CBT group and TAU group.Conclusions: CBT improved HRQoL, Illness Perception and reduced Depressive symptoms in atrial fibrillation.